Oxford Biomedica is headquartered in Oxford, United Kingdom.
Oxford Biomedica disclosed revenue of 129M GBP for 2024 and 90M GBP for 2023.
Oxford Biomedica has 900 employees.
Oxford Biomedica is a life science company.
Oxford Biomedica was founded in 1996.
Windrush Court, Transport Way,
Oxford,
OX4 6LT
United Kingdom,
+44 (0) 1865 783 000
www.oxb.com
Oxford Biomedica is a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno associated virus, adenoviral vectors, and other viral vector types. Oxford Biomedica was founded in 1995 and is based in Oxford, United Kingdom.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
